{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:48:52Z","timestamp":1790113732706,"version":"4.0.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T00:00:00Z","timestamp":1630108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005624","name":"Medizinischen Hochschule Hannover","doi-asserted-by":"publisher","award":["HILF II program and transplantation center project 19_02"],"award-info":[{"award-number":["HILF II program and transplantation center project 19_02"]}],"id":[{"id":"10.13039\/501100005624","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB738 project Z2"],"award-info":[{"award-number":["SFB738 project Z2"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1111\/ajt.16817","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T22:44:33Z","timestamp":1630190673000},"page":"519-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation"],"prefix":"10.1016","volume":"22","author":[{"given":"Emily A.","family":"Saunders","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastian","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"H\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Hartleben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian W.R.","family":"Vondran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrej","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Zender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmar","family":"Jaeckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-2496","authenticated-orcid":false,"given":"Richard","family":"Taubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1111\/ajt.16817_bib1","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/j.1600-6143.2010.03126.x","article-title":"Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study","volume":"10","author":"Watt","year":"2010","journal-title":"Am J Transplant."},{"issue":"10","key":"10.1111\/ajt.16817_bib2","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJMoa021744","article-title":"Chronic renal failure after transplantation of a nonrenal organ","volume":"349","author":"Ojo","year":"2003","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1111\/ajt.16817_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/SLA.0000000000002650","article-title":"No gains in long-term survival after liver transplantation over the past three decades","volume":"269","author":"Rana","year":"2019","journal-title":"Ann Surg."},{"issue":"3","key":"10.1111\/ajt.16817_bib4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jhep.2012.04.015","article-title":"Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR)","volume":"57","author":"Adam","year":"2012","journal-title":"J Hepatol."},{"issue":"7","key":"10.1111\/ajt.16817_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1600-6143.2012.04047.x","article-title":"Renal comorbidity after solid organ and stem cell transplantation","volume":"12","author":"Clajus","year":"2012","journal-title":"Am J Transplant."},{"issue":"12","key":"10.1111\/ajt.16817_bib6","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1097\/00007890-200112270-00012","article-title":"End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy: risk of development and treatment","volume":"72","author":"Gonwa","year":"2001","journal-title":"Transplant."},{"issue":"4","key":"10.1111\/ajt.16817_bib7","doi-asserted-by":"crossref","first-page":"e13227","DOI":"10.1111\/ctr.13227","article-title":"Histopathology of 460 liver allografts removed at retransplantation: a shift in disease patterns over 27 years","volume":"32","author":"Neves Souza","year":"2018","journal-title":"Clin Transplant."},{"issue":"6","key":"10.1111\/ajt.16817_bib8","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/j.transproceed.2009.06.120","article-title":"Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation","volume":"41","author":"Zimmermann","year":"2009","journal-title":"Transplant Proc."},{"issue":"5","key":"10.1111\/ajt.16817_bib9","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/ctr.12352","article-title":"Safety and performance of liver biopsies in liver transplant recipients","volume":"28","author":"Alten","year":"2014","journal-title":"Clin Transplant."},{"issue":"3","key":"10.1111\/ajt.16817_bib10","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jhep.2018.04.012","article-title":"Molecular profiling of subclinical inflammatory lesions in long-term surviving adult liver transplant recipients","volume":"69","author":"Londo\u00f1o","year":"2018","journal-title":"J Hepatol."},{"issue":"6","key":"10.1111\/ajt.16817_bib11","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2018.08.023","article-title":"Evidence of chronic allograft injury in liver biopsies from long-term pediatric recipients of liver transplants","volume":"155","author":"Feng","year":"2018","journal-title":"Gastroenterol."},{"issue":"3","key":"10.1111\/ajt.16817_bib12","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/TP.0000000000003034","article-title":"DSA are associated with more graft injury, more fibrosis, and upregulation of rejection-associated transcripts in subclinical rejection","volume":"104","author":"H\u00f6fer","year":"2020","journal-title":"Transplant."},{"issue":"7","key":"10.1111\/ajt.16817_bib13","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.24427","article-title":"Preferential accumulation of T helper cells but not cytotoxic T cells characterizes benign subclinical rejection of human liver allografts","volume":"22","author":"Baumann","year":"2016","journal-title":"Liver Transpl."},{"issue":"1","key":"10.1111\/ajt.16817_bib14","doi-asserted-by":"crossref","first-page":"14242","DOI":"10.1038\/s41598-020-70938-7","article-title":"Non-invasive screening for subclinical liver graft injury in adults via donor-specific anti-HLA antibodies","volume":"10","author":"H\u00f6fer","year":"2020","journal-title":"Sci Rep."},{"issue":"5","key":"10.1111\/ajt.16817_bib15","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep.26426","article-title":"Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients","volume":"58","author":"Ben\u00edtez","year":"2013","journal-title":"Hepatol."},{"issue":"2","key":"10.1111\/ajt.16817_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/hep.31036","article-title":"Immunosuppression withdrawal in liver transplant recipients on sirolimus","volume":"72","author":"Levitsky","year":"2020","journal-title":"Hepatol."},{"issue":"3","key":"10.1111\/ajt.16817_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/jama.2011.2014","article-title":"Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants","volume":"307","author":"Feng","year":"2012","journal-title":"JAMA."},{"issue":"10","key":"10.1111\/ajt.16817_bib18","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/ajt.13909","article-title":"2016 comprehensive update of the banff working group on liver allograft pathology: introduction of antibody-mediated rejection","volume":"16","author":"Demetris","year":"2016","journal-title":"Am J Transplant."},{"issue":"2","key":"10.1111\/ajt.16817_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.jhep.2010.10.044","article-title":"Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis","volume":"55","author":"Patsenker","year":"2011","journal-title":"J Hepatol."},{"key":"10.1111\/ajt.16817_bib20","doi-asserted-by":"crossref","first-page":"e926476","DOI":"10.12659\/AOT.926476","article-title":"Suppression of allograft fibrosis by regulation of mammalian target of rapamycin-related protein expression in kidney-transplanted recipients treated with everolimus and reduced tacrolimus","volume":"26","author":"Nishioka","year":"2021","journal-title":"Ann Transplant."},{"issue":"2","key":"10.1111\/ajt.16817_bib21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.5500\/wjt.v4.i2.133","article-title":"Everolimus immunosuppression reduces the serum expression of fibrosis markers in liver transplant recipients","volume":"4","author":"Fern\u00e1ndez-Yunquera","year":"2014","journal-title":"World J Transplant."},{"issue":"10","key":"10.1111\/ajt.16817_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/apt.15253","article-title":"Systematic review with meta-analysis: sirolimus- or everolimus-based immunosuppression following liver transplantation for hepatocellular carcinoma","volume":"49","author":"Grigg","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"10.1111\/ajt.16817_bib23","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/tid.12601","article-title":"Role of mTOR inhibitors for the control of viral infection in solid organ transplant recipients","volume":"18","author":"Pascual","year":"2016","journal-title":"Transpl Infect Dis."},{"issue":"11","key":"10.1111\/ajt.16817_bib24","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"de Simone","year":"2012","journal-title":"Am J Transplant."},{"issue":"4","key":"10.1111\/ajt.16817_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/j.1523-1755.2005.00602.x","article-title":"BK virus nephritis: risk factors, timing, and outcome in renal transplant recipients","volume":"68","author":"Vasudev","year":"2005","journal-title":"Kidney Int."},{"issue":"1","key":"10.1111\/ajt.16817_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J."},{"issue":"12","key":"10.1111\/ajt.16817_bib27","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1097\/TP.0b013e318176b1fd","article-title":"Protocol liver allograft biopsies","volume":"85","author":"Mells","year":"2008","journal-title":"Transplant."},{"issue":"2","key":"10.1111\/ajt.16817_bib28","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hep.28681","article-title":"Five-year histological and serological follow-up of operationally tolerant pediatric liver transplant recipients enrolled in WISP-R","volume":"65","author":"Feng","year":"2017","journal-title":"Hepatol."},{"key":"10.1111\/ajt.16817_bib29","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ebiom.2016.05.040","article-title":"Progressive fibrosis is driven by genetic predisposition, allo-immunity, and inflammation in pediatric liver transplant recipients","volume":"9","author":"Varma","year":"2016","journal-title":"EBioMedicine."},{"issue":"8","key":"10.1111\/ajt.16817_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/lt.21781","article-title":"Late protocol liver biopsies in the liver allograft: a neglected investigation?","volume":"15","author":"Mells","year":"2009","journal-title":"Liver Transpl."},{"key":"10.1111\/ajt.16817_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.12659\/AOT.901487","article-title":"Clinical impact of liver biopsies in liver transplant recipients","volume":"22","author":"Voigtl\u00e4nder","year":"2017","journal-title":"Ann Transplant."},{"issue":"11","key":"10.1111\/ajt.16817_bib32","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/lt.25879","article-title":"Time to conversion to an everolimus-based regimen: renal outcomes in liver transplant recipients from the EVEROLIVER registry","volume":"26","author":"Saliba","year":"2020","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1111\/ajt.16817_bib33","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/TP.0000000000003394","article-title":"Efficacy and safety of everolimus with reduced tacrolimus in liver transplant recipients: 24-month results from the pooled analysis of two randomized controlled trials","volume":"105","author":"Lee","year":"2021","journal-title":"Transplant."},{"key":"10.1111\/ajt.16817_bib34","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1111\/ajt.12280","article-title":"Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study","volume":"13","author":"Saliba","year":"2013","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.16817_bib35","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1111\/ajt.14212","article-title":"Efficacy and safety of everolimus and mycophenolic acid with early tacrolimus withdrawal after liver transplantation: a multicenter randomized trial","volume":"17","author":"Saliba","year":"2017","journal-title":"Am J Transplant."},{"issue":"3","key":"10.1111\/ajt.16817_bib36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/ajt.12615","article-title":"Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation","volume":"14","author":"Sterneck","year":"2014","journal-title":"Am J Transplant."},{"issue":"7","key":"10.1111\/ajt.16817_bib37","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1111\/j.1600-6143.2012.04049.x","article-title":"A randomized, controlled study to assess the conversion from calcineurin-inhibitors to everolimus after liver transplantation\u2013PROTECT","volume":"12","author":"Fischer","year":"2012","journal-title":"Am J Transplant."},{"issue":"5","key":"10.1111\/ajt.16817_bib38","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/TP.0000000000002980","article-title":"Randomized sirolimus-based early calcineurin inhibitor reduction in liver transplantation: impact on renal function","volume":"104","author":"Buchholz","year":"2020","journal-title":"Transplant."},{"key":"10.1111\/ajt.16817_bib39","doi-asserted-by":"crossref","first-page":"101690","DOI":"10.1016\/j.bpg.2020.101690","article-title":"Renal disease in the allograft recipient","volume":"46\u201347","author":"Nevens","year":"2020","journal-title":"Best Pract Res Clin Gastroenterol."},{"issue":"9","key":"10.1111\/ajt.16817_bib40","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1002\/lt.25293","article-title":"Longterm survival and cost-effectiveness of immunosuppression withdrawal after liver transplantation","volume":"24","author":"Manzia","year":"2018","journal-title":"Liver Transpl."}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16817","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajt.16817","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522080959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522080959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajt.16817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:36:18Z","timestamp":1761629778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522080959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S1600613522080959"],"URL":"https:\/\/doi.org\/10.1111\/ajt.16817","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcome and safety of a surveillance biopsy guided personalized immunosuppression program after liver transplantation","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/ajt.16817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}